
Oncologist

No OPD information available
Pancreatic Cancer
Colorectal Cancer
Neuroendocrine Tumor
Pancreatectomy
Pancreatic Ductal Adenocarcinoma
Pancreatic Islet Cell Tumor
Small Cell Lung Cancer (SCLC)
Lorraine A. Chantrill is a female doctor who helps people with different types of cancer like pancreatic cancer, colorectal cancer, and neuroendocrine tumors. She is skilled in performing surgeries like pancreatectomy to remove parts of the pancreas affected by cancer. She also treats specific types of cancer such as pancreatic ductal adenocarcinoma, pancreatic islet cell tumors, and small cell lung cancer.
Dr. Chantrill cares for her patients by talking to them in a way that makes them feel comfortable and understood. Patients trust her because she listens to their concerns and explains things clearly. She stays updated with the latest medical knowledge and research to provide the best care for her patients.
Dr. Chantrill works well with other medical professionals, collaborating with colleagues to ensure patients receive comprehensive care. She has published research on targeting specific signaling pathways in pancreatic cancer to improve treatment outcomes. Additionally, she is involved in a clinical trial investigating the use of aspirin in treating colorectal cancer.
Through her work, Dr. Chantrill has positively impacted many patients' lives by providing effective treatments and compassionate care. Her dedication to advancing cancer care and her commitment to staying informed about the latest advancements make her a trusted and respected healthcare provider.
In summary, Lorraine A. Chantrill is a skilled and caring doctor who specializes in treating various types of cancer. She communicates effectively with patients, stays updated on medical research, collaborates with colleagues, and conducts research to improve cancer treatments. Her work has made a significant difference in the lives of her patients, demonstrating her dedication to providing high-quality healthcare.
Enrollment Status: Active not recruiting
Published: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
